Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of the warfarin enantiomers in rats.

Literature DB >> 4452939

Pharmacokinetics of the warfarin enantiomers in rats.

A Yacobi, G Levy.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1974 PMID： 4452939 DOI： 10.1007/BF01059764

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

13 in total

1. The plasma half-lives of the enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats.

Authors: D S Hewick
Journal: J Pharm Pharmacol Date: 1972-08 Impact factor: 3.765

2. Effect of phenylbutazone on the distribution, elimination and anticoagulant action of dicumarol in rats.

Authors: E Jähnchen; L B Wingard; G Levy
Journal: J Pharmacol Exp Ther Date: 1973-10 Impact factor: 4.030

3. Kinetics of anticoagulant effect of dicumarol in rats.

Authors: L B Wingard; G Levy
Journal: J Pharmacol Exp Ther Date: 1973-01 Impact factor: 4.030

4. Letter: Effect of plasma protein binding on elimination of warfarin.

Authors: G Levy; A Yacobi
Journal: J Pharm Sci Date: 1974-05 Impact factor: 3.534

5. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.

Authors: A Yacobi; L B Wingard; G Levy
Journal: J Pharm Sci Date: 1974-06 Impact factor: 3.534

6. Interaction of several coumarin compounds with human and canine plasma albumin.

Authors: R A O'Reilly
Journal: Mol Pharmacol Date: 1971-03 Impact factor: 4.436

7. The assay of warfarin in plasma or stool.

Authors: R J Lewis; L P Ilnicki; M Carlstrom
Journal: Biochem Med Date: 1970-12

8. Letter: Pharmacokinetics of (+)-, (-)- and (plus or minus)-hexobarbitone in man after oral administration.

Authors: D D Breimer; J M van Rossum
Journal: J Pharm Pharmacol Date: 1973-09 Impact factor: 3.765

9. Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.

Authors: D S Hewick; J McEwen
Journal: J Pharm Pharmacol Date: 1973-06 Impact factor: 3.765

10. Synthesis and relative urinary excretion rates of the enantiomers of warfarin-4-14C and phenprocoumon-2-14C.

Authors: L A Goding; B D West
Journal: J Med Chem Date: 1969-05 Impact factor: 7.446

8 in total

1. Species-dependent stereospecific serum protein binding of the oral anticoagulant drug phenprocoumon.

Authors: W Schmidt; E Jähnchen
Journal: Experientia Date: 1978-10-15

2. Protein binding of warfarin enantiomers in serum of humans and rats.

Authors: A Yacobi; G Levy
Journal: J Pharmacokinet Biopharm Date: 1977-04

Review 3. Drug interactions with warfarin.

Authors: M J Serlin; A M Breckenridge
Journal: Drugs Date: 1983-06 Impact factor: 9.546

4. Drug interactions with warfarin enantiomers--a different perspective.

Authors: L B Wingard; G Levy
Journal: Br J Clin Pharmacol Date: 1978-11 Impact factor: 4.335

5. Anticoagulant activity of the enantiomers of acenocoumarol.

Authors: T Meinertz; W Kasper; C Kahl; E Jähnchen
Journal: Br J Clin Pharmacol Date: 1978-02 Impact factor: 4.335

6. Demonstration of stereoselective disposition of warfarin enantiomers by whole-body autoradiography.

Authors: I Szinai; M Simonyi; I Fitos; Z Tegyey; A Magyar
Journal: Eur J Drug Metab Pharmacokinet Date: 1990 Apr-Jun Impact factor: 2.441

7. Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients.

Authors: Suman Lal; Edwin Sandanaraj; Srinivasa Rao Jada; Ming-Chai Kong; Lai-Heng Lee; Boon-Cher Goh; Soo-Chin Lee; Balram Chowbay
Journal: Br J Clin Pharmacol Date: 2007-11-08 Impact factor: 4.335

8. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.

Authors: H H Thijssen; L G Baars; H T Vervoort-Peters
Journal: Br J Pharmacol Date: 1988-11 Impact factor: 8.739

8 in total